Despite the prevalence of nonalcoholic fatty liver disease, the most common liver disease worldwide, there are currently no approved pharmacotherapies for nonalcoholic fatty liver disease.

Read More > https://mash.pocn.com/diagnosis/genetic-insights-offer-new-hope-for-nonalcoholic-fatty-liver-disease-treatment/